USSTOCK.TODAY
Regular Market Log in Sign up

VivoSim Labs signs seven-figure deal with top 10 global pharmaceutical company

InvestorsHub +1 · ·by G4L

VIVS
VIVS VivoSim Labs Inc
$0.29 +142.92%
View chart & analysis →
  1. 1VivoSim Labs has signed a seven-figure contract with a top 10 global pharmaceutical company.
  2. 2VivoSim Labs expects to exceed its FY2027 revenue growth guideline by more than 500%.
  3. 3VivoSim Labs announced a collaboration with Kemveda Life Sciences on November 3.

So what's the key point?

VivoSim Labs signed a large contract with a global pharmaceutical company. Revenue for 2027 is expected to be more than 500% higher than projected.

Source InvestorsHub +1 · View original ↗

Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →